Document is current

Article History

Received: 18 December 2023

Revised: 16 May 2024

Accepted: 7 June 2024

First Online: 17 June 2024

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Ethics Committee from Ruprecht-Karls University of Heidelberg (trial registration number: S-621/2021) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

: R. Khoramnia reports grants, personal fees, and nonfinancial support from Johnson & Johnson Vision, Alcon Laboratories, Hoya Corp., Kowa Co., Ltd., Oculentis GmbH/Teleon, Physiol S.A., Sifi Medtech Srl, and Rayner Intraocular Lenses Ltd.; grants and personal fees from Oculus Optikgeräte GmbH, Carl Zeiss Meditec AG, and Ophtec BV; and grants from Acufocus Inc. outside the submitted work. G.U. Auffarth reports lecture fees and research grants from Johnson & Johnson Vision, Alcon Laboratories, Carl Zeiss Meditec AG, Hoya Corp., Kowa Co., Ltd., Oculentis GmbH/Teleon, Physiol S.A., Rayner Intraocular Lenses Ltd., Oculus Optikgeräte GmbH, Ophthec BV, Santen, Sifi Medtech Srl, Acufocus Inc., Novartis, Ursapharm and Biotech; nonfinancial support from Rheacell, Contamac, Cristalens, Croma, EyeYon, Hanita, and VSY outside the submitted work. V. A. Augustin reports research grants from Eye Yon and Kowa Co. outside the submitted work. The remaining authors have no relevant financial or non-financial interests to disclose.